InsidersTradesSigma
华仁药业 Stock: price and insider trades · China · SSE / SZSE (CSRC)
Track the 华仁药业 stock price and the full management transaction log of the company, a listed equity based in China. Shares are quoted on CN CN, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 华仁药业 has logged 9 insider filings. Market capitalisation: €3.7bn. The latest transaction was reported on 6 February 2024 (Purchase). Among the most active insiders: 杨效东. All data is free.
9
Insider Decl.
0
Thresholds
·
9 ops.
Buy Volume
·
0 ops.
Sell Volume
29Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 19,056 of 25,567 companies
35.1
score / 100
Value48
Quality22
FCF yld11%
Earn yld-15%
EV/EBITDA·
ROE-40%
Gross mgn37%
Net mgn-35%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 6 February 2024
Declarations9 total
9 of 9 declarations